Around the nation: FDA announces nationwide shortage of Adderall – The Daily Briefing
What you need to know about the forces reshaping our industry.
October 17, 2022
FDA announced a nationwide shortage of Adderall, an ADHD medication, as manufacturers struggle to meet growing demand, in today’s bite-sized hospital and health industry news from the District of Columbia, Maryland, and Ohio.
Share:
Current ArticleAround the nation: FDA announces nationwide shortage of Adderall
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.
© 2022 Advisory Board. All rights reserved.
